Hepatitis B immune globulin - Biotest AG

Drug Profile

Hepatitis B immune globulin - Biotest AG

Alternative Names: BT-088; Fovepta; HBVIg - Biotest AG; Hepatect; Hepatect CP; Hepatect FH; Human hepatitis B immunoglobulin - Biotest AG; Neohepatect; Zutectra

Latest Information Update: 05 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biotest AG
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 23 Apr 2015 Biotest files an MAA application with the EMA in European Union early use hepatitis B immunoglobulin in Hepatitis B (prevention of relapse in liver transplant patients)
  • 23 Apr 2015 Efficacy and adverse events data from the phase III ZEUS trial in Hepatitis B (prevention of relapse in liver transplant patients) released by Biotest
  • 01 Jan 2013 Merz Pharma acquires marketing rights for Neohepatect® in Russia, from Biotest AG
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top